Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The investigators hypotheses that paclitaxel combined with cisplatin in a weekly-based regimen as adjuvant chemotherapy is more effective for high risk, HER2 negative breast cancer .
Epistemonikos ID: 0dba00d08f600a459c6b3dff547c83a90e297f1a
First added on: May 20, 2024